A Supreme Court case that will determine the fate of Roe v. Wade—the landmark ruling that legalized abortion nationwide—has intensified pressure to permanently nix a requirement to only give out pills ending early pregnancy in-person.
Doctors, abortion rights advocates, and some members of Congress say ensuring easy access to the drug mifepristone is especially critical now that abortion protections are at stake. The high court hears argument Wednesday in Dobbs v. Jackson Women’s Health Organization, a Mississippi appeal that seeks to overturn Roe.
“It is long past time for the FDA to put science ahead of stigma and ...